Werewolf Therapeutics, Inc.HOWLNASDAQ
Loading
EPS Growth TrendStable
Percentile Rank68
3Y CAGR-28.1%
Studio
Year-over-Year Change

Year-over-year earnings per share growth rate

3Y CAGR
-28.1%/yr
Quarterly compound
Percentile
P68
Within normal range
vs 3Y Ago
0.4x
Contraction
Streak
1 qtr
Consecutive growthStable
PeriodValue
Q3 202510.00%
Q2 20250.00%
Q1 202513.04%
Q4 2024-21.05%
Q3 20245.00%
Q2 2024-2.56%
Q1 2024-18.18%
Q4 2023-43.48%
Q3 2023-64.29%
Q2 202358.82%
Q1 20232.86%
Q4 20227.89%
Q3 202226.92%
Q2 20227.14%
Q1 202215.15%
Q4 2021-29.41%
Q3 202186.65%
Q2 20212.05%
Q1 20210.00%
Q4 2020100.00%
Q3 2020-372.00%
Q2 2020158.14%
Q1 20200.00%